Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of aesthetics and medical dermatology. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company